posted on 2024-11-30, 04:03authored byHan Zhang, Kaiyuan Song, Yihan Liu, Fang Yang, Congcong Lu, Rumeng Wei, Zhijue Xu, Xia Zou, Liang Lin, Ting Shi, Lin-Tai Da, Yan Zhang
Tumor-associated MUC1 is coated with a high density of
O-GalNAc
glycans, which are initiated by a family of polypeptide N-acetyl-α-galactosaminyltransferases
(GalNAc-Ts). However, the O-glycosylation process of MUC1 by each
GalNAc-T isoform remains unclear. Here, we successfully obtained 14
human GalNAc-Ts with high catalytic activity based on a bacterial
expression system. Employing MUC1-derived peptides as substrates,
we systematically investigated the catalytic properties and site specificity
of these GalNAc-Ts by chromatography and mass spectrometry, and found
that they could be classified into two clusters. These two GalNAc-T
clusters initially catalyze the threonine residue within GSTA or GVTS motifs, respectively,
resulting in high O-glycosylation occupancy of both motifs. Moreover,
molecular dynamics simulations and site-directed mutagenesis confirmed
that the initial O-glycosite preference of GalNAc-Ts on MUC1 is controlled
by two critical residues within the peptide-binding pocket. Swapping
of the corresponding residues between two GalNAc-T clusters could
exchange their initial O-glycosite preference. Quantum mechanics calculations
further revealed the detailed catalytic mechanisms of GalNAc-Ts. Our
work contributes to understanding the catalytic synthesis of multisite
O-glycosylation of MUC1 by GalNAc-Ts, facilitating the development
of O-glycosite-specific MUC1 vaccines.